Ledger.Open graph →
SEC Form D · filed March 31, 2022

2seventy bio, Inc

Offering
$170.0M
Sold
$170.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Philip D. Gregory · CAMBRIDGE, MAExecDaniel D. Lynch · CAMBRIDGE, MADirectorSarah J. Glickman · CAMBRIDGE, MADirectorDaniel D. Lynch · CAMBRIDGE, MADirectorMarcela V. Maus · CAMBRIDGE, MADirectorWilliam D. Baird · CAMBRIDGE, MAExecSarah J. Glickman · CAMBRIDGE, MADirectorWilliam R. Sellers · Cambridge, MADirectorRamy R. Ibrahim · CAMBRIDGE, MADirectorDenice R. Torres · Cambridge, MADirectorPhilip D. Gregory · CAMBRIDGE, MAExecWilliam D. Baird · CAMBRIDGE, MAExecRamy R. Ibrahim · CAMBRIDGE, MADirectorNick Leschly · Cambridge, MAExec · DirectorDenice R. Torres · Cambridge, MADirectorWilliam R. Sellers · Cambridge, MADirectorMarcela V. Maus · CAMBRIDGE, MADirectorNick Leschly · Cambridge, MAExec · DirectorNicola Heffron · CAMBRIDGE, MAExecNicola Heffron · CAMBRIDGE, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗